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ABSTRACT
Background: Myocardial perfusion imaging (MPI) is a powerful diagnostic and prognostic tool for evaluating 
coronary artery disease (CAD). Several studies have shown Type 2 diabetics are at increased risk for having 
CAD. In addition, insulin resistance is generally considered to be of major importance in the pathophysiology 
of Type 2 diabetes mellitus. However, the area of screening prediabetics for CAD remains unclear. Given that 
glucose intolerance and insulin resistance precede the development of overt diabetes, these factors would be 
associated with CAD. Aim: This study was designed to evaluate the state of myocardial perfusion in prediabetic 
adults detected by single photon emission computed tomography (SPECT) in relation to insulin resistance. 
Patients and Methods: A descriptive study was performed. Out of 113 consecutive prediabetic adults, 32 had 
insulin resistance (Group A) and 81 had insulin sensitivity (Group B). All were subjected to full medical history 
and clinical examination including blood pressure, waist circumference, and body mass index. Biochemical 
studies including lipids proﬁ  le, fasting blood glucose, and homeostasis model assessments (HOMA) test. 
Exercise treadmill technetium (99mTC) sestamibi SPECT scintigraphy were done for assessment of myocardial 
perfusion assessed by summed difference score as well as occurrence of transient left ventricular dilatation. 
Results: Signiﬁ  cant increase in summed difference score as well as transient left ventricular dilatation was 
observed in Group A than Group B. It is correlated with insulin resistance, and the correlation appears to be 
independent of glucose tolerance status and obesity. Similar correlations were observed with age, triglycerides, 
and waist circumference. Conclusion: Prediabetics have myocardial perfusion defects which represent a pattern 
of cardiovascular risk. These are predominantly observed in prediabetics with increased HOMA IR and visceral 
obesity independent of glucose levels.
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INTRODUCTION
Prediabetes broadly refers to an intermediate stage 
between completely normal glucose levels and the clinical 
entity of Type 2 diabetes. Diabetes mellitus, hypertension, 
dyslipidemia, obesity, and aging are associated with high 
risk of cardiovascular disease (CVD) as well as other 
clinical conditions[1]
The mechanisms through which cardiovascular risk is 
increased are partially understood. Myocardial perfusion 
imaging (MPI) is a powerful diagnostic and prognostic tool 
for evaluating coronary artery disease (CAD). Prognostic 
indicators on MPI include the severity of both ﬁ  xed and 
reversible perfusion defects (myocardial infarction and 
ischemia),[2] reduced left ventricular function after stress,[3,4] 
and dilation of the left ventricle after stress.[5-7] Given 
that glucose intolerance and insulin resistance precede 
the development of overt diabetes, these factors would 
be associated with ischemic heart disease and perfusion 
defects. To investigate this hypothesis, the current study was 
undertaken to evaluate the state of myocardial perfusion 
in prediabetic adults in relation to insulin resistance. Stress 
single-photon emission computed tomographic myocardial 
perfusion imaging (SPECT) performed with technetium 
(Tc)-99m–labeled radiopharmaceuticals is widely used 
for diagnosing CAD and assessing patient risk. Patients 
determined to have a normal SPECT on the basis of stress Nasr and Sliem: Myocardial perfusion in prediabetic adults detected by SPECT
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imaging alone have a similar mortality rate as those who 
have a normal SPECT on the basis of evaluation of both 
stress and rest images.[8]
PATIENTS AND METHODS
Study population
A descriptive study enrolling 113 consecutive adults with 
prediabetes with an age range of 40–50 years was carried 
out. All were recruited from the outpatient diabetes and 
general medicine clinics of Suez Canal University Hospital 
from May 2007 to October 2009. Thirty-two adults had 
insulin resistance (Group A) and 81 had insulin sensitivity 
(Group B). Exclusion criteria included hypertension, 
diabetes mellitus, chronic kidney disease, CVD, severe 
obesity (body mass index > 40 kg/m2), heavy smokers, and 
aged adults (over 60 years old). All groups were subjected 
to full medical history and clinical examination including 
blood pressure (BP), body mass index (BMI), systemic 
examination, and biochemical studies. Anthropometric 
measures were weight in kilogram, height in centimeter, 
body mass index, and waist circumference. Body mass 
index was calculated as weight/height2 (kg/m2) and was 
used as an estimate of overall adiposity. Normal weight, 
overweight, and obesity were defined as a BMI less 
than 25, 25–29.9, and 30 or higher, respectively.[8] Waist 
circumference, a validated estimate of visceral adiposity, 
was measured to the nearest 0.5 cm. Central obesity is 
deﬁ  ned as waist circumference > 102 cm in males and 
>88 cm in females.[9] 
Diabetes was diagnosed according to World Health 
Organization (WHO) criteria. Blood is drawn after fasting 
for 8 h. A fasting blood sugar level below 100 mg/dL is 
considered normal. A fasting blood sugar level between 
100 and 126 mg/dL conﬁ  rms the presence of prediabetes, 
and more than 126 mg/dL conﬁ  rms the presence of 
diabetes in two separate occasions.[10] Homeostasis model 
of insulin resistance (HOMA IR) was used as a measure 
of insulin resistance. It was assessed according to the 
level of fasting glucose and insulin which were measured 
with a dextran–charcoal radioimmunoassay. Serum intact 
proinsulin was measured by using a highly specific, 
2-site monoclonal antibody-based immunoradiometric 
assay:[10,11]
The formula for the HOMA IR model is as follows:
HOMA IR = (Fasting insulin, mU/mL × Fasting glucose, 
mmol/L)/22.5.
Subjects were divided by their insulin resistance status at 
baseline (HOMA IR above and below median of 3.0) to 
insulin resistant and insulin sensitive, respectively.[10] 
Exercise treadmill technetium-99m sestamibi SPECT 
scintigraphy
All prediabetics were scheduled for a treadmill test using an 
automated programmable treadmill Bruce protocol. Each 
was examined before the test and 12 lead ECG was recorded 
and read. Blood pressure was measured by arm-cuff method 
with an aneroid sphygmomanometer and a stethoscope 
for auscultation. ST segment depression was measured in 
millimeter at 80ms from the J point and considered signiﬁ  cant 
when >1 mm from the baseline. Criteria for stopping the 
test were: target heart rate achieved, occurrence of chest 
pain or signiﬁ  cant ST segment depression, hypertensive or 
hypotensive blood pressure response or failure of blood 
pressure to rise >10 mmHg, serious cardiac arrhythmia, and 
patients request to stop. Both the duration of the exercise 
and reason for stopping were recorded. The radiotracer 8–10 
mCi of Tc99m-sestamibi injected through an intravenous 
cannula when one of the following occurred: target heart rate 
achieved, appearance of signiﬁ  cant ST segment depression, 
and significant chest pain. Then, the exercise test was 
continued for another 45–60 s and then the test terminated. 
Tomographic imaging was performed 1 h later. 
Interpretation of exercise ECG
An ischemic ST segment response was defined as 
horizontal or down sloping ST segment depression >1 mm 
below baseline 80 ms from the J point. Functional capacity 
measured in metabolic equivalents (or METs, where one 
MET is 3.5 mL/kg per min of oxygen consumption.
Reconstruction and interpretation of the technetium- 
99m-sestamibi
Imaging was acquired on rotating gamma camera (Anger 
Scintillation Gamma Camera, General Electric—Maxi 
Camera 400 AC) equipped with a general all-purpose 
collimator interfaced to a dedicated computer system. 
Acquisition in 32 stops each for 40 s in 64 × 64 matrix 
imaging was performed through three windows. Oblique 
tomograms are generated in vertical and horizontal long 
axis and short axis orientation using an operator-dependent 
computerized algorism. The tomograms then normalized 
so the hottest pixel for each orientation for both exercise 
and delayed tomograms is set to uniform intensity. The 
myocardium segments usually interpreted for the presence 
of perfusion abnormalities. 
The summed stress and rest scores were obtained by 
adding the scores of the 20 segments of the respective 
images.[12] The sum of the differences between each of 
the 20 segments from these images was deﬁ  ned as the Nasr and Sliem: Myocardial perfusion in prediabetic adults detected by SPECT
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summed difference score, representing the amount of 
ischemia. Each of these variables incorporates the extent 
and severity of perfusion. The summed difference score 
was converted to percent myocardium ischemia according 
to a published ≥ algorithm. “Ischemic” and “moderately 
to severely ischemic”  where  MPS studies were deﬁ  ned 
by ≥5 and ≥10% of the myocardium, respectively.[12] 
Images were also interpreted visually and by consensus 
for the presence or absence of transient ischemic dilation 
by two experienced observers who were unaware of the 
clinical ﬁ  ndings. 
Ethical consideration
Informed consent was obtained from all the adults. The aim 
and the value of the work were explained in a simpliﬁ  ed 
manner for them. There was no harm inﬂ  icted on them. 
On the contrary, all had beneﬁ  ts of the follow-up and the 
ﬁ  nal results of the study. In addition, it was a descriptive 
study in prediabetics as it is unethical to perform the test 
in otherwise normal non-risky controls.
Statistical analysis
Data were presented in terms of mean and standard 
deviation (SD) of the mean, and percentages. Statistical 
analysis was carried out by a computer program (SPSS Ver. 
11). ANOVA and correlation tests were used to evaluate 
the results between the three groups. P value was set at 
<0.05 for statistically signiﬁ  cant results and <0.0001 for 
highly signiﬁ  cant results. Logistic regression analysis was 
used to assess odds ratio.
RESULTS
Descriptive baseline characteristics of 113 (60 males and 
53 females) prediabetic adults, mean age 43.1 years, with 
and without insulin resistance are shown in Table 1. Of 
them, 36.2% of the prediabetic adults had insulin resistance 
and 63.8% had insulin sensitive. Except for the waist 
circumference, all the mentioned parameters were nearly 
similar in both male and female prediabetic adults.
Correlation between summed difference score and 
different variables of insulin-resistant prediabetic group 
(Group A) is shown in Table 2. There was statistically 
signiﬁ  cant coefﬁ  cient correlation with HOMA IR, waist 
circumference, triglycerides, and age. No correlation 
was observed with fasting glucose, BMI, blood pressure, 
and total lipids. Similarly, no correlations were found 
with overall prediabetic population variables. The visual 
consensus method of determining the presence or absence 
of transient ischemic dilation resulted in classiﬁ  cation of 
11 of 113 persons as having transient ischemic dilation 
(9.7%). In the insulin-resistant group, it was 7/32 (21.9%) 
and lastly in the insulin-sensitive group it was 4/81 (4.9%).
DISCUSSION
It is well known that Type 2 diabetes mellitus is associated 
with a marked increase in CVD. Increased risk factors 
for CVD before the onset of Type 2 diabetes have been 
shown in several populations.[1,13,14] It is not known whether 
the increased atherogenicity of the prediabetic state is 
primarily due to increased insulin resistance or impaired 
blood glucose.[15]
It has been recognized that prediabetic hyperglycemia 
confers an increased risk for cardiovascular disease 
(CVD).[16,17]  In 1997, the American Diabetes Association 
(ADA) introduced the concept of impaired fasting 
glucose (IFG), a prediabetic state initially deﬁ  ned by 
fasting plasma glucose (FPG) of 110–125mg/dL, in 
which those afﬂ  icted were signiﬁ  cantly more likely to 
develop diabetes.  [18-20] The risk of developing CVD was 
not considered in establishing criteria for IFG. Since 
the introduction of the concept of IFG, there has been 
considerable debate regarding where the lower limit 
should be set to achieve a reasonable balance between 
sensitivity and speciﬁ  city for diabetes prediction. In 2003, 
the ADA lowered its threshold for diagnosis of IFG from 
110 mg/dL to 100 mg/dL on the basis of evidence in 
selected samples that suggested diabetes prediction may 
be optimized at a lower threshold.[21] The effect of this 
lowered cut point is that a much larger proportion of 
the population is now considered to have IFG. Using 
data from the Third National Health and Nutrition 
Examination Survey, Benjamin et al.[22] found that the 
prevalence of IFG among adults was estimated to increase 
from 8.3% to 30.2%.
In the context of current literature, conﬂ  icting data exist 
regarding the effect of nondiabetic fasting hyperglycemia 
on cardiovascular risk. Although some studies have found 
that the 1997 IFG deﬁ  nition is associated with signiﬁ  cantly 
increased risk for CVD,[23,24] others have shown no 
signiﬁ  cantly increased risk for CVD with the 1997 IFG 
deﬁ  nition.[25-27]
The progression from prediabetes to Type 2 diabetes 
occurs over many years before the development of overt 
hyperglycemia seen in diabetes.[28,29] However, the state Nasr and Sliem: Myocardial perfusion in prediabetic adults detected by SPECT
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of perfusion in prediabetes has received little attention. 
We, therefore, studied prediabetic normotensive adults in 
whom the prevalence of insulin resistance and impaired 
glucose tolerance is high to test the hypotheses that insulin 
resistance is associated with myocardial perfusion defects 
and that this relationship is dependent or independent of 
glucose tolerance status.
The main ﬁ  nding of this study is that insulin resistance 
is associated with myocardial perfusion defects and that 
the association appears to be independent of glucose 
tolerance status and obesity. Results from this study did 
not identify an increase in myocardial perfusion defects 
among individuals with insulin-sensitive prediabetes. 
Furthermore, no correlation was found between them and 
fasting glucose measurements. Our data suggest that insulin 
resistance may be more important in the development of 
myocardial perfusion defects .The mechanism underlying 
the relationship between insulin resistance and myocardial 
perfusion defects is not clear enough. Prediabetes is 
not only a significant risk factor for progression to 
Type 2 diabetes, but is also considered a risk factor for 
macrovascular disease and for retinopathy. Some of this risk 
may be associated with progression to overt diabetes, but 
there is still increased risk in individuals who have not yet 
progressed to diabetes. A meta-analysis of 38 prospective 
studies, for example, suggests that postchallenge blood 
glucose levels in the nondiabetic range appear to have a 
linear relationship with cardiovascular disease risk and a 
possible threshold risk with FPG of about 100 mg/dL.[30]
The risk of progressing to diabetes depends on the degree 
of insulin resistance and deﬁ  ciency of insulin secretion as 
well as other diabetes risk factors, such as age, family history, 
overweight/obesity, or history of gestational diabetes.[31,32] 
Previous studies have shown that visceral fat in young 
healthy individuals and older adults is associated with 
increased cardiovascular risk factors.[33] This study conﬁ  rms 
this association. Although it is observed that abdominal 
adiposity as measured by waist circumference was strongly 
and adversely associated with myocardial perfusion defects, 
body mass index as a measure of general adiposity was not. 
In addition, this study found that insulin resistance appears 
to be more strongly associated with perfusion defects than 
with measures of obesity. These results suggest that the 
obesity–perfusion defects relationship may be mediated 
in part through increasing insulin resistance. In general, 
adipocytes, in particular from visceral abdominal regions, 
produce several bioactive peptides which in turn impact 
on microcirculation.[34,35] However, impact of hypertension 
upon microcirculation was ameliorated as all subjects were 
normotensives, such the association was not held. On the 
other hand, total lipids had insigniﬁ  cant correlation with 
myocardial perfusion defects. When the components of the 
lipids were considered separately, perfusion defect showed 
Table 2: Correlation between summed difference score 
and different variables in insulin-resistant prediabetics 
Variable r 
value
P value Variable r 
value
P 
value
Age 0.84 <0.01 Total lipids 0.44 n.s.
Total 
cholesterol
0.11 n.s. Systolic blood 
pressure
0.38 n.s.
Low density 
lipoprotein
0.24 n.s. Diastolic blood 
pressure
0.36 n.s.
Triglyceride 0.79 <0.01 High density 
lipoprotein
0.24 n.s.
HOMA IR 0.92 <0.001 Fasting blood 
glucose
0.18 n.s.
Waist 
circumference
0.87 <0.01 Body mass index 0.18 n.s.
n.s. = Nonsigniﬁ  cant.
Table 1: Clinical and biochemical studies of prediabetics
Variable Prediabetic adults (case), N = 113 P value
All, N = 113 Group A, N = 32 Group B, N = 81 P* P** P***
Age
SBP
DBP
BMI
Waist circumference
Total lipids
Triglycerides
FBG
HOMA IR
Sum dif. score 
Trans isch. dilation
45.1 + 6.2
122.2 ± 9.2
73.9 ± 6.9
28.4 ± 5.2
103 ± 17.2
491 ± 31.9
187.7 ± 12.4
114.5 ± 4.8
3.7 ± 2.5
3.11 ± 1.31
11/113 (9.7%)
44.9 ± 7.1
120.9 ± 7.9
74.9 ± 6.5
28.5 ± 5.2
107 ± 11.6
479 ± 26.7
187 ±14.2
114.8 ± 4.6
7.5 ± 0.7
11.87 ± 3.91
7/32 (21.9%) 
45.3 ± 5.9
120.1 ± 9.5
73.5 ± 7.1
28.4 ± 5.1
102.5 ± 18.2
499.7 ± 36.4
188.5 ± 11.9
115.7 ± 4.9
2.2 ± 0.4
2.89 ± 1.72
4/81 (4.9%) 
n.s
n.s
n.s
n.s
n.s
n.s
n.s
<0.01
<0.01
<0.001
<0.01
n.s
n.s
n.s
n.s
n.s
n.s
n.s
<0.01
<0.01
<0.01
<0.01
n.s
n.s
n.s
n.s
n.s
n.s
n.s
n.s
n.s
n.s
n.s
Group A = Prediabetic adult with insulin resistance; Group B = prediabetic adult with insulin sensitivity; BMI = body mass index; SBP = systolic blood pressure; DBP = 
diastolic BP; N = number of cases; n.s = nonsigniﬁ  cant; FBG = fasting blood glucose; Sum dif score = Summed difference score; Trans isch dilatation = transient ischemic 
dilation. P* = Comparison between Group A and Group B.  P** = Comparison between  prediabetic adults and Group A. P*** = Comparison between all prediabetic adults 
and Group B.Nasr and Sliem: Myocardial perfusion in prediabetic adults detected by SPECT
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direct associations only with triglycerides in this study, 
age was an independent predictor of having perfusion 
defects. It is known that different arterial segments respond 
differently to aging.[36]
In conclusion, we have shown that prediabetics have 
myocardial perfusion defects which represent a pattern of 
cardiovascular risk, and these changes are predominantly 
observed in prediabetics with increased HOMA IR and 
visceral obesity. As the silent ischemic changes in the 
prediabetic state are limited to subjects with insulin 
resistance, the use of insulin-sensitizing agents to 
prevent diabetes could have a beneﬁ  cial effect on CVD. 
None of the studied prediabetic adult had symptomatic 
cardiac disease. The findings of this study revealed 
that changes can be detected before the appearance of 
clinically apparent coronary myocardial perfusion defects  
and may act as a marker for the development of future 
CVD. It is likely that over the next few years screening 
for ischemic in asymptomatic prediabetics for perfusion 
defects will become an increasingly important part of 
the process of risk assessment, and may possibly also 
improve the monitoring of therapy.[30] However, these 
studies are beyond doubt have limitations regarding 
radiation exposure, cost, and feasibility. Additional studies 
will be needed to assess the effect of an improvement in 
insulin sensitivity to improve the myocardial perfusion 
as well to investigate cost effectiveness of using SPECT 
in prediabetics.
It is important to note several limitations in this study 
design, ﬁ  rst, the relatively small sample size. Second, this 
study enrolled a relatively population of older individuals 
carefully screened to exclude diabetes and hypertension. 
Further research will be needed to conﬁ  rm whether these 
results generalize to middle-aged, more insulin-sensitive 
individuals and those with hypertension through a large 
community-based study. Further studies are needed for 
prevention of Type 2 diabetes and the prediabetic state 
as well.
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